Clinical Trial Update: Clinical Study of SU011248 in Subjects With High Risk Prostate Cancer Who Have Elected to Undergo Radical Prostatectomy [Phase 1]

View source ↗

Summary

Phase 1 clinical trial of SU011248 in high-risk prostate cancer patients undergoing radical prostatectomy has completed enrollment/status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• SU011248

Snippet

Sponsor: Jonsson Comprehensive Cancer Center | Conditions: Prostate Cancer | Phase 1 | Status: COMPLETED